How is Increasing Cancer Prevalence Propelling Embolotherapy Market?

 More than 840,000 new liver cancer cases were diagnosed around the world in 2018, according to the World Cancer Research Fund (WCRF). Similarly, other severe diseases, such as kidney cancer, aneurysms, and varicose veins, are also increasing in prevalence due to genetic predisposition, environmental factors, sedentary lifestyle, obesity, and alcohol abuse. 

Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/embolotherapy-market/report-sample

Several embolic agents and support devices are used for the procedure, of which embolic agents are used more. This is because of the advent of technologically advanced agents, such as radioactive Y-90 microspheres, which are utilized in the treatment of primary and secondary liver diseases, as well as calibrated microspheres, which are used during bland embolization. Moreover, the usage of embolic agents is increasing in interventional radiology procedures, which further helps augment the demand for these embolotherapy products.

Make an Enquiry before Purchase:  https://www.psmarketresearch.com/send-enquiry?enquiry-url=embolotherapy-market

Apart from the rising incidence of the diseases mentioned above, the increasing number of people being diagnosed in the intermediate or advanced stages is another reason for the surging volume of embolotherapy procedures. Often, patients in the later stages of diseases, especially cancer or end-stage liver cirrhosis, do not respond to curative procedures, including surgical resection, ablation, and liver transplantation. Therefore, to make them comfortable and as stable as possible, for as long as possible, embolotherapy is being provided.

Comments

Popular posts from this blog

Huge Growth Expected in Dermacosmetics Market in Future

Increasing Occurrence of Spinal Cord Injuries Powering Sales of Exoskeletons

Why is Population Health Management Market Expected to Boom in North America in Future?